Sumitomo Mitsui Trust Group Inc. cut its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 75.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 74,778 shares of the company’s stock after selling 233,713 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.06% of Clorox worth $6,058,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. acquired a new stake in Clorox during the 2nd quarter worth about $958,640,000. Bank of America Corp DE acquired a new stake in shares of Clorox during the second quarter valued at approximately $179,780,000. Royal Bank of Canada raised its holdings in shares of Clorox by 20.1% during the first quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock valued at $146,969,000 after acquiring an additional 237,301 shares during the period. ProShare Advisors LLC lifted its position in shares of Clorox by 6.3% in the 3rd quarter. ProShare Advisors LLC now owns 1,737,891 shares of the company’s stock valued at $140,787,000 after acquiring an additional 102,732 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Clorox by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock valued at $132,670,000 after acquiring an additional 29,181 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Clorox
In related news, Director Pierre Breber purchased 4,000 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was bought at an average price of $100.06 per share, for a total transaction of $400,240.00. Following the purchase, the director owned 22,000 shares in the company, valued at $2,201,320. The trade was a 22.22% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.51% of the stock is owned by corporate insiders.
Clorox Stock Up 0.1%
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.07 by $0.48. Clorox had a net margin of 9.41% and a return on equity of 601.88%. The company had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.88 billion. During the same quarter in the prior year, the business posted $0.85 EPS. Clorox’s quarterly revenue was up 33.3% on a year-over-year basis. As a group, equities analysts anticipate that The Clorox Company will post 5.76 earnings per share for the current fiscal year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 5.0%. The ex-dividend date is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is 89.93%.
Wall Street Analyst Weigh In
CLX has been the subject of a number of recent analyst reports. Citigroup decreased their price objective on shares of Clorox from $97.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, October 14th. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 29th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 6th. Wells Fargo & Company lifted their target price on shares of Clorox from $85.00 to $90.00 and gave the company an “equal weight” rating in a research note on Tuesday. Finally, JPMorgan Chase & Co. boosted their price target on shares of Clorox from $83.00 to $86.00 and gave the company an “underweight” rating in a report on Tuesday. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $93.79.
Check Out Our Latest Research Report on Clorox
About Clorox
The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.
Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.
See Also
- Five stocks we like better than Clorox
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
